Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats

Objective: The high global incidence of type 2 diabetes has challenged researchers to establish animal models that resemble the chronic stage observed in type 2 diabetes patients. One such model is induced by neonatal streptozotocin (n-STZ) administration to rat pups at 0, 2, or 5 days after birth....

Full description

Bibliographic Details
Main Authors: Belinda Vargas Guerrero, Pedro M García López, Ana E González Santiago, José A Domínguez Rosales, Carmen M Gurrola Díaz
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Biological Research
Subjects:
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602013000300009&lng=en&tlng=en
_version_ 1828766465382154240
author Belinda Vargas Guerrero
Pedro M García López
Ana E González Santiago
José A Domínguez Rosales
Carmen M Gurrola Díaz
author_facet Belinda Vargas Guerrero
Pedro M García López
Ana E González Santiago
José A Domínguez Rosales
Carmen M Gurrola Díaz
author_sort Belinda Vargas Guerrero
collection DOAJ
description Objective: The high global incidence of type 2 diabetes has challenged researchers to establish animal models that resemble the chronic stage observed in type 2 diabetes patients. One such model is induced by neonatal streptozotocin (n-STZ) administration to rat pups at 0, 2, or 5 days after birth. In this study, we assessed lns-1 gene expression and tissue insulin levels as well as serum concentration of glucose and insulin, insulin resistance, and histological changes of the islets of Langerhans in n5-STZ rats after 20-weeks post-induction. Methods: Wistar rat pups were randomly distributed into a control group and a streptozotocin-induced group. Experimental induction involved a single intraperitoneal injection of streptozotocin (150 mg/kg) into neonates at five days after birth. Results: At 20 weeks post-induction, streptozotocin-induced rats exhibited increased serum glucose levels, reduced serum insulin levels, impaired glucose metabolism and insulin resistance compared to control rats. Histologically, streptozotocin-induced rats exhibited atrophic islets, vacuolization, and significantly fewer insulin-positive cells. lns-1 gene expression was significantly decreased in n5-STZ rats in comparison to the control group. Conclusion: Our findings support that the n5-STZ model 20 weeks post-induction represents an appropriate experimental tool to study T2D and to evaluate novel therapeutic agents and targets that involve insulin gene expression and secretion, as well as complications caused by chronic diabetes.
first_indexed 2024-12-11T07:06:39Z
format Article
id doaj.art-ae217b397b2041d79f15f7824ac8e82d
institution Directory Open Access Journal
issn 0716-9760
language English
last_indexed 2024-12-11T07:06:39Z
publishDate 2013-01-01
publisher BMC
record_format Article
series Biological Research
spelling doaj.art-ae217b397b2041d79f15f7824ac8e82d2022-12-22T01:16:29ZengBMCBiological Research0716-97602013-01-0146328128810.4067/S0716-97602013000300009S0716-97602013000300009Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ ratsBelinda Vargas Guerrero0Pedro M García López1Ana E González Santiago2José A Domínguez Rosales3Carmen M Gurrola Díaz4Universidad de GuadalajaraUniversidad de GuadalajaraUniversidad de GuadalajaraUniversidad de GuadalajaraUniversidad de GuadalajaraObjective: The high global incidence of type 2 diabetes has challenged researchers to establish animal models that resemble the chronic stage observed in type 2 diabetes patients. One such model is induced by neonatal streptozotocin (n-STZ) administration to rat pups at 0, 2, or 5 days after birth. In this study, we assessed lns-1 gene expression and tissue insulin levels as well as serum concentration of glucose and insulin, insulin resistance, and histological changes of the islets of Langerhans in n5-STZ rats after 20-weeks post-induction. Methods: Wistar rat pups were randomly distributed into a control group and a streptozotocin-induced group. Experimental induction involved a single intraperitoneal injection of streptozotocin (150 mg/kg) into neonates at five days after birth. Results: At 20 weeks post-induction, streptozotocin-induced rats exhibited increased serum glucose levels, reduced serum insulin levels, impaired glucose metabolism and insulin resistance compared to control rats. Histologically, streptozotocin-induced rats exhibited atrophic islets, vacuolization, and significantly fewer insulin-positive cells. lns-1 gene expression was significantly decreased in n5-STZ rats in comparison to the control group. Conclusion: Our findings support that the n5-STZ model 20 weeks post-induction represents an appropriate experimental tool to study T2D and to evaluate novel therapeutic agents and targets that involve insulin gene expression and secretion, as well as complications caused by chronic diabetes.http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602013000300009&lng=en&tlng=enchronic hyperglycemiain vivo diabetes modelslns-1 genetype 2 diabetes
spellingShingle Belinda Vargas Guerrero
Pedro M García López
Ana E González Santiago
José A Domínguez Rosales
Carmen M Gurrola Díaz
Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
Biological Research
chronic hyperglycemia
in vivo diabetes models
lns-1 gene
type 2 diabetes
title Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
title_full Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
title_fullStr Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
title_full_unstemmed Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
title_short Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
title_sort reduction of lns 1 gene expression and tissue insulin levels in n5 stz rats
topic chronic hyperglycemia
in vivo diabetes models
lns-1 gene
type 2 diabetes
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602013000300009&lng=en&tlng=en
work_keys_str_mv AT belindavargasguerrero reductionoflns1geneexpressionandtissueinsulinlevelsinn5stzrats
AT pedromgarcialopez reductionoflns1geneexpressionandtissueinsulinlevelsinn5stzrats
AT anaegonzalezsantiago reductionoflns1geneexpressionandtissueinsulinlevelsinn5stzrats
AT joseadominguezrosales reductionoflns1geneexpressionandtissueinsulinlevelsinn5stzrats
AT carmenmgurroladiaz reductionoflns1geneexpressionandtissueinsulinlevelsinn5stzrats